Evidence map›Paper›PMID 26563764›Full record

ArticleScientific reports2015

Determinants of ligand binding and catalytic activity in the myelin enzyme 2',3'-cyclic nucleotide 3'-phosphodiesterase.

Arne Raasakka, Matti Myllykoski, Saara Laulumaa, Mari Lehtimäki, Michael Härtlein, Martine Moulin, Inari Kursula, Petri Kursula

Open access · goldAbstract read
In one paragraph

Article in Scientific reports, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 22 papers.

0numbers the graph read from it
0cells of the map it votes in
22citing papers in PubMed
1.6field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

22 citing papers in PubMed, 35 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. The Sts Proteins: Modulators of Host Immunity.International journal of molecular sciences · 2023
    Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Review
  15. Article
  16. Article
  17. Article
  18. Article
  19. Olig2 Silence Ameliorates Cuprizone-Induced Schizophrenia-Like Symptoms in Mice.Medical science monitor : international medical journal of experimental and clinical research · 2017
    Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 4 institutions in 4 countries.

Arne RaasakkaFaculty of Biochemistry and Molecular Medicine, University of Oulu, Oulu, Finland.
Matti MyllykoskiFaculty of Biochemistry and Molecular Medicine, University of Oulu, Oulu, Finland.
Saara LaulumaaFaculty of Biochemistry and Molecular Medicine, University of Oulu, Oulu, Finland.
Mari LehtimäkiFaculty of Biochemistry and Molecular Medicine, University of Oulu, Oulu, Finland.
Michael HärtleinInstitut Laue-Langevin (ILL), Grenoble, France.
Martine MoulinInstitut Laue-Langevin (ILL), Grenoble, France.
Inari KursulaFaculty of Biochemistry and Molecular Medicine, University of Oulu, Oulu, Finland.
Petri KursulaFaculty of Biochemistry and Molecular Medicine, University of Oulu, Oulu, Finland.
University of Oulu · FIInstitut Laue-Langevin · FRUniversity of Bergen · NOEuropean Spallation Source · SE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

2',3'-cyclic nucleotide 3'-phosphodiesterase (CNPase) is an enzyme highly abundant in the central nervous system myelin of terrestrial vertebrates. The catalytic domain of CNPase belongs to the 2H phosphoesterase superfamily and catalyzes the hydrolysis of nucleoside 2',3'-cyclic monophosphates to nucleoside 2'-monophosphates. The detailed reaction mechanism and the essential catalytic amino acids involved have been described earlier, but the roles of many amino acids in the vicinity of the active site have remained unknown. Here, several CNPase catalytic domain mutants were studied using enzyme kinetics assays, thermal stability experiments, and X-ray crystallography. Additionally, the crystal structure of a perdeuterated CNPase catalytic domain was refined at atomic resolution to obtain a detailed view of the active site and the catalytic mechanism. The results specify determinants of ligand binding and novel essential residues required for CNPase catalysis. For example, the aromatic side chains of Phe235 and Tyr168 are crucial for substrate binding, and Arg307 may affect active site electrostatics and regulate loop dynamics. The β5-α7 loop, unique for CNPase in the 2H phosphoesterase family, appears to have various functions in the CNPase reaction mechanism, from coordinating the nucleophilic water molecule to providing a binding pocket for the product and being involved in product release.

Indexed as

Protein Structure, Tertiary2',3'-Cyclic Nucleotide 3'-PhosphodiesteraseAnimalsBinding SitesBiocatalysisCatalytic DomainCircular DichroismCrystallography, X-RayKineticsLigandsMass SpectrometryMiceModels, MolecularMutationMyelin SheathProtein Binding2',3'-Cyclic Nucleotide 3'-PhosphodiesteraseLigands

Identifiers

PMID26563764
PMCPMC4643303
OpenAlexW2409175377

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.